Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Predicting the Anticancer Activity of 2-alkoxycarbonylallyl Esters against MDA-MB-231 Breast Cancer - QSAR, Machine Learning and Molecular Docking

2022Current Drug Discovery TechnologiesJournal

10.2174/1570163819666220811094019 Full text1 citations

Authors

7 authors across 3 institutions in 2 countries.

Oluwatoba Emmanuel OyeneyinFirst authorCorresponding
- Adekunle Ajasin University (NG)
Babatunde Samuel Obadawo
Adesoji Alani Olanrewaju
- Bowen University (NG)
Damilohun Samuel Metibemu
- Adekunle Ajasin University (NG)
Sunday Adeola Emaleku
- Adekunle Ajasin University (NG)
T.O. Owolabi
- Adekunle Ajasin University (NG)
as printed: Taoreed Olakunle Owolabi
Nureni IpinlojuSenior author
- Adekunle Ajasin University (NG)

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Enzyme function and inhibitionlevel 3 · 0.99
Computational Drug Discovery Methodslevel 3 · 0.00
Cholinesterase and Neurodegenerative Diseaseslevel 3 · 0.00

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 9, 2026
2022 · Current Drug Discovery Technologies · 1 citations
https://openalex.org/W4298040211

Predicting the Anticancer Activity of 2-alkoxycarbonylallyl Esters against MDA-MB-231 Breast Cancer - QSAR, Machine Learning and Molecular Docking · Sankore